Skip to main content

Table 1 Clinical data

From: Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas

Patient INSS INRG Age at diagnosis (months) Follow up or outcome change (months) Outcome 1p loss MNA 11q loss Origin
26R9 1 L 2 91 NED neg neg neg Adrenal gland
25R9 2 L 111 95 NED neg neg neg NA
20R9 2 L 3 113 NED neg neg NA NA
27R7 2 L 0 92 NED neg neg neg Intraspinal abdominal
33R7 2 L 3 92 NED neg neg neg NA
13E8 2 L 32 202 NED neg neg neg NA
15E7 3 L 0 0 DSC neg neg neg NA
15E3 3 L 12 195 NED neg neg neg NA
25R0 3 L 1 97 NED neg neg neg Thorax
13E6 3 L 48 12 DOD pos pos pos NA
11R4 3 L 15 27 DOD pos pos neg NA
10R8 3 L 80 59 DOD neg neg pos NA
9R9 3 L 24 21 DOD pos neg pos NA
10R2 4 M 15 12 DOD pos pos neg NA
15R3 4 M 28 9 DOD pos neg pos Adrenal gland
34R0 4 M 64 11 DOD neg neg neg Abdominal
17R2 4 M 80 45 DOD neg neg pos NA
26R8 4 M 21 18 DOD pos pos NA NA
28R8 4 M 29 26 DOD neg neg pos Adrenal gland
16E9 4 M 19 5 DOD neg pos neg NA
39R1 4 M 22 29 NED pos pos neg Abdominal
  1. Abbreviations: INSS, International neuroblastoma staging system; INRG, International neuroblastoma risk group; MNA, MYCN amplification; NA, Information not available; L, Localized; M, Metastasized; NED, No evidence of disease; DOD, Dead of disease; DSC, Dead by surgical complications; pos, Positive; neg, Negative.